Investor Alert: Perimeter Medical - US FDA 510K Clearance on O.C.T. Imaging System

March 25, 2021

Providing surgeons with ultra-high-resolution, “real time” imaging information

Perimeter Medical Imaging AI Inc. is developing ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. Moreover, the recent 510(k) clearance from the U.S. FDA enables Perimeter to bring its “commercial-ready” Optical Coherence Tomography (OCT) Imaging System to the U.S. market.

Perimeter’s OCT Imaging System

With advanced technology and intuitive functionality, Perimeter’s OCT Imaging System is designed to examine tissue microstructures during surgical procedures. Further, it provides cross-sectional, real-time margin visualization with image review manipulation software that allows physicians to identify and annotate microscopic tissue structures.

Throughout its development, Perimeter listened to clinician users. In fact, they incorporated their feedback to deliver a product that allows for a streamlined integration into current intraoperative workflows. Perimeter’s OCT Imaging system provides physicians and clinicians with “real-time” margin visualization to assist their decision making.

“We are thrilled to be bringing physicians real-time margin visualization to assist their decision making, help create better patient outcomes, and lower healthcare costs” says CEO, Jeremy Sobotta.

Perimeter’s OCT Imaging System is a foundational building block as the company continues to develop ‘next-gen’ improvements, such as the artificial intelligence tools currently in development under the ATLAS AI project.

For more information on Perimeter Medical Imaging AI, Inc. (TSX.V: PINK, OTC: PYNKF) please click the request investor info button.

You might also like

Healthcare
Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Healthcare
Investor Alert - Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, YouTube and more!